生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | BRDs (bromodomains) of human proteome can recognize the relaxed chromatin segments and bind to the acetylated nucleosomes, transcription factors and co-activators. (+)-JQ1 is a potent and selective bromodomain inhibitor with IC50 values of 77nM, 33nM and >10uM for BRD4(1), BRD4(2) and CREBBP, respectively[1]. The (+)-JQ-1-specific inhibition of BRDs can affect the production of the targeted transcription factor-dependent protein, including NRF2-dependent HO-1, NADPH:quinone oxidoreductase-1 as well as GCLC, SOCS3, STAT5-mediated regulation of target genes, RUNX3, SIRT1, MYC and its downstream target genes, etc.[2]. JQ1 can induce the differentiation and growth arrest in NUT midline carcinoma. Treatment with (+)-JQ-1, 250nM for 48h, potently decreased the expression of both BRD4 target genes, RAD21 and RAN, in NMC cells. Treatment with JQ1, i.p., 50mg/kg for 18 days, can regress the tumor growth and prolong overall survival of NMC797 xenografted mice. In addition, (-)-JQ-1 is the negative control compound of (+)-JQ-1[1]. | ||
作用机制 | JQ1 can bind lysine acetylation binding site of BET bromodomains competitively with chromatin in a cellular environment.[1] |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
148I | Growth Inhibition Assay | 72 h | IC50=0.284±0.035 μM | 25944566 | |
148I | 0.25/0.5/1.0 μM | Apoptosis Assay | 24 h | increases levels of cleaved caspase-3 | 25944566 |
148I | 1 μM | Apoptosis Assay | 48 h | induces cell apoptosis significantly | 25944566 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.19mL 0.44mL 0.22mL |
10.94mL 2.19mL 1.09mL |
21.88mL 4.38mL 2.19mL |
参考文献 |
---|